What Has Changed
Health Canada has stated that Version 4.0 is not a new framework, but it introduces more prescriptive detail and additional expectations.
Key areas to note include:
- A restructured format that follows the order of the Natural Health Product Regulations.
- Expanded expectations for company-wide quality systems, with more emphasis on senior management accountability.
- More detailed requirements for stability programs, corrective and preventive action plans, and recall systems, including mock recalls.
- New directions for companies that import products, including testing, documentation, and control of labels.
- Additional requirements for records, including the use of electronic systems, electronic signatures, and ensuring documents are available in English or French.
- Clarifications on the use of approaches such as reduced testing or quantification by input, but with clear documentation requirements to justify these choices.
Transition Period
- September 4, 2025 – March 4, 2026: Transition period. Companies are encouraged to begin reviewing and adjusting their procedures in light of the new guidance.
- March 4, 2026: Version 3 will be withdrawn and Version 4 will be the sole reference document.
What This Means for Members
CHFA previously encouraged Natural Health Product members to review the draft guidance during the consultation period. With the document now finalized, we strongly recommend that all members involved in the manufacturing, packaging, labeling, importing, or distribution of Natural Health Products carefully review the new Good Manufacturing Practices guide as soon as possible, as it introduces requirements that will affect day-to-day operations.
For many companies, Version 4.0 will mean adjustments to systems, procedures, and documentation practices. Areas such as translation of records, validation of electronic systems, importer responsibilities, and more formal recall planning are likely to require focused attention.
While the guide adds detail and clarity in some areas, members may find that the changes increase expectations and create new compliance pressures.
CHFA’s Role and Next Steps
CHFA has raised concerns about the limited engagement that took place during the development of this document. We remain committed to:
- Monitoring implementation and identifying where requirements may create unintended or disproportionate challenges for members.
- Seeking clarifications from Health Canada on sections that are overly prescriptive or create uncertainty.
- Supporting members with tools and training, including a webinar and practical resources to help interpret and apply the new guidance.
- Advocating for proportional enforcement during the transition, particularly for small and medium-sized businesses.
- Educating members on the changes. Join us at CHFA NOW Toronto, September 19 for a session on Navigating Compliance with Gowlings WLG. See conference schedule for more details.
Share Your Feedback
Member experiences and input are critical at this stage. Please share any challenges you anticipate in applying the new guidance with us at regulatory@chfa.ca.
This feedback will shape our ongoing engagement with Health Canada.
